These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 15368205)

  • 1. Safety of aprotinin in heparinized and nonheparinized patients.
    Levy JH
    J Cardiothorac Vasc Anesth; 2004 Aug; 18(4 Suppl):38S-42S. PubMed ID: 15368205
    [No Abstract]   [Full Text] [Related]  

  • 2. A strategy for reducing blood-transfusion requirements in elective orthopaedic surgery.
    Booth D; Kothmann E; Tidmarsh M
    J Bone Joint Surg Br; 2004 Mar; 86(2):309-10; author reply 310. PubMed ID: 15046454
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of aprotinin to reduce blood loss and transfusion in major orthopedic surgery: a meta-analysis.
    Huang F; Zhao Q; Guo C; Ma G; Wang Q; Yin Y; Wu Y
    Transfus Apher Sci; 2014 Oct; 51(2):152-61. PubMed ID: 25129829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin.
    Dietrich W; Spannagl M; Boehm J; Hauner K; Braun S; Schuster T; Busley R
    Anesth Analg; 2008 Nov; 107(5):1469-78. PubMed ID: 18931201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety issues in heparin and protamine administration for extracorporeal circulation.
    Jobes DR
    J Cardiothorac Vasc Anesth; 1998 Apr; 12(2 Suppl 1):17-20. PubMed ID: 9583571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Use of aprotinin during pediatric heart surgery].
    Martín Burcio S; Valiño González J; Domínguez F; Díaz Balda J; Martínez M; Vellibre D
    Rev Esp Anestesiol Reanim; 2001 May; 48(5):212-6. PubMed ID: 11412731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aprotinin.
    Alston TA
    Int Anesthesiol Clin; 2004; 42(4):81-91. PubMed ID: 15577702
    [No Abstract]   [Full Text] [Related]  

  • 8. Efficacy of aprotinin with various anticoagulant agents in cardiopulmonary bypass.
    Terrell MR; Walenga JM; Koza MJ; Pifarré R
    Ann Thorac Surg; 1996 Aug; 62(2):506-11. PubMed ID: 8694614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined use of aprotinin and a heparin-bonded cardiopulmonary bypass system for aortic aneurysm repair.
    Gallagher JM; Brown ME; Gasior TA
    J Cardiothorac Vasc Anesth; 1995 Dec; 9(6):728-30. PubMed ID: 8664469
    [No Abstract]   [Full Text] [Related]  

  • 10. Reduction of blood loss using high-dose aprotinin in major orthopaedic surgery.
    Slappendel R; Dirksen R; Van Hellemondt GG
    J Bone Joint Surg Br; 2004 May; 86(4):620; author reply 620-1. PubMed ID: 15174566
    [No Abstract]   [Full Text] [Related]  

  • 11. Transfusion avoidance in orthopedic surgery.
    Cushner FD
    J Cardiothorac Vasc Anesth; 2004 Aug; 18(4 Suppl):29S-30S. PubMed ID: 15368203
    [No Abstract]   [Full Text] [Related]  

  • 12. Aprotinin and major orthopedic surgery.
    Samama CM
    Eur Spine J; 2004 Oct; 13 Suppl 1(Suppl 1):S56-61. PubMed ID: 15235943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Aprotinin in the control of surgical hemorrhage].
    Rocha E; Antonio Páramo J; Hermida J
    Med Clin (Barc); 1996 Mar; 106(8):307-16. PubMed ID: 8667690
    [No Abstract]   [Full Text] [Related]  

  • 14. Pro: Aprotinin has a good efficacy and safety profile relative to other alternatives for prevention of bleeding in cardiac surgery.
    Body SC; Mazer CD
    Anesth Analg; 2006 Dec; 103(6):1354-9. PubMed ID: 17122202
    [No Abstract]   [Full Text] [Related]  

  • 15. Monitoring activated clotting time for combined heparin and aprotinin application: an in vitro evaluation of a new aprotinin-insensitive test using SONOCLOT.
    Ganter MT; Dalbert S; Graves K; Klaghofer R; Zollinger A; Hofer CK
    Anesth Analg; 2005 Aug; 101(2):308-314. PubMed ID: 16037133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood conservation in liver transplantation: The role of aprotinin.
    Porte RJ; Hendriks HG; Slooff MJ
    J Cardiothorac Vasc Anesth; 2004 Aug; 18(4 Suppl):31S-37S. PubMed ID: 15368204
    [No Abstract]   [Full Text] [Related]  

  • 17. Aprotinin in major orthopedic surgery: a systematic review of randomized controlled trials.
    Shiga T; Wajima Z; Inoue T; Sakamoto A
    Anesth Analg; 2005 Dec; 101(6):1602-1607. PubMed ID: 16301226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ICVTS on-line discussion A Plateletpheresis or aprotinin, which is the key element?
    Kan CD
    Interact Cardiovasc Thorac Surg; 2007 Oct; 6(5):622; discussion 622. PubMed ID: 17884856
    [No Abstract]   [Full Text] [Related]  

  • 19. Drugs to minimize perioperative blood loss in cardiac surgery: meta-analyses using perioperative blood transfusion as the outcome. The International Study of Peri-operative Transfusion (ISPOT) Investigators.
    Laupacis A; Fergusson D
    Anesth Analg; 1997 Dec; 85(6):1258-67. PubMed ID: 9390590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Con: Aprotinin should not be used in cardiac surgery with cardiopulmonary bypass.
    Augoustides JG
    J Cardiothorac Vasc Anesth; 2007 Apr; 21(2):302-4. PubMed ID: 17418754
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.